10x Genomics, Inc. 1KJ.F Stock
10x Genomics, Inc. Price Chart
10x Genomics, Inc. 1KJ.F Financial and Trading Overview
10x Genomics, Inc. stock price | 20.71 EUR |
Previous Close | 49.68 EUR |
Open | 50.7 EUR |
Bid | 51.32 EUR x N/A |
Ask | 51.56 EUR x N/A |
Day's Range | 50.7 - 50.7 EUR |
52 Week Range | 29.48 - 57.18 EUR |
Volume | 20 EUR |
Avg. Volume | 7 EUR |
Market Cap | 6.18B EUR |
Beta (5Y Monthly) | 1.878 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.06 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 197.56 EUR |
1KJ.F Valuation Measures
Enterprise Value | 5.73B EUR |
Trailing P/E | N/A |
Forward P/E | -281.66666 |
PEG Ratio (5 yr expected) | 3.22 |
Price/Sales (ttm) | 10.450302 |
Price/Book (mrq) | 8.041238 |
Enterprise Value/Revenue | 9.704 |
Enterprise Value/EBITDA | -36.589 |
Trading Information
10x Genomics, Inc. Stock Price History
Beta (5Y Monthly) | 1.878 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 57.18 EUR |
52 Week Low | 29.48 EUR |
50-Day Moving Average | 39.69 EUR |
200-Day Moving Average | 45.47 EUR |
1KJ.F Share Statistics
Avg. Volume (3 month) | 7 EUR |
Avg. Daily Volume (10-Days) | 15 EUR |
Shares Outstanding | 104.15M |
Float | 101.63M |
Short Ratio | N/A |
% Held by Insiders | 2.28% |
% Held by Institutions | 89.98% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -37.79% |
Operating Margin (ttm) | -34.75% |
Gross Margin | 69.87% |
EBITDA Margin | -26.52% |
Management Effectiveness
Return on Assets (ttm) | -12.15% |
Return on Equity (ttm) | -29.37% |
Income Statement
Revenue (ttm) | 590.98M EUR |
Revenue Per Share (ttm) | 5.09 EUR |
Quarterly Revenue Growth (yoy) | 17.19% |
Gross Profit (ttm) | 396.02M EUR |
EBITDA | -156734000 EUR |
Net Income Avi to Common (ttm) | -223362000 EUR |
Diluted EPS (ttm) | -1.74 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 356.91M EUR |
Total Cash Per Share (mrq) | 3.02 EUR |
Total Debt (mrq) | 98.47M EUR |
Total Debt/Equity (mrq) | 13.21 EUR |
Current Ratio (mrq) | 5.37 |
Book Value Per Share (mrq) | 6.305 |
Cash Flow Statement
Operating Cash Flow (ttm) | -27232000 EUR |
Levered Free Cash Flow (ttm) | -46822000 EUR |
Profile of 10x Genomics, Inc.
Country | Germany |
State | CA |
City | Pleasanton |
Address | 6230 Stoneridge Mall Road |
ZIP | 94588-3260 |
Phone | 925 401 7300 |
Website | https://www.10xgenomics.com |
Industry | Health Information Services |
Sector(s) | Healthcare |
Full Time Employees | 1243 |
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Q&A For 10x Genomics, Inc. Stock
What is a current 1KJ.F stock price?
10x Genomics, Inc. 1KJ.F stock price today per share is 20.71 EUR.
How to purchase 10x Genomics, Inc. stock?
You can buy 1KJ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 10x Genomics, Inc.?
The stock symbol or ticker of 10x Genomics, Inc. is 1KJ.F.
Which industry does the 10x Genomics, Inc. company belong to?
The 10x Genomics, Inc. industry is Health Information Services.
How many shares does 10x Genomics, Inc. have in circulation?
The max supply of 10x Genomics, Inc. shares is 121.61M.
What is 10x Genomics, Inc. Price to Earnings Ratio (PE Ratio)?
10x Genomics, Inc. PE Ratio is now.
What was 10x Genomics, Inc. earnings per share over the trailing 12 months (TTM)?
10x Genomics, Inc. EPS is -2.06 EUR over the trailing 12 months.
Which sector does the 10x Genomics, Inc. company belong to?
The 10x Genomics, Inc. sector is Healthcare.